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Data herein describe the quantitative changes in the plasma pro-
teome in chickens challenged with lipopolysaccharide (LPS), a
bacterial endotoxin known to stimulate the host innate immune
system obtained by shotgun quantitative proteomic tandem mass
tags approach using high-resolution Orbitrap technology. Statis-
tical and bioinformatic analyses were performed to specify the
effect of bacterial endotoxin. Plasma from chicken (N¼6) chal-
lenged with Escherichia coli (LPS) (2mg/kg body weight) was col-
lected pre (0 h) and at 12, 24, 48, and 72 h post injection along
with plasma from a control group (N¼6) challenged with sterile
saline. Protein identiﬁcation and relative quantiﬁcation were per-
formed using Proteome Discoverer, and data were analysed using
R. Gene Ontology terms were analysed by the Cytoscape applica-
tion ClueGO based on Gallus gallus GO Biological Process database,
and reﬁned by REVIGO. Absolute quantiﬁcation of several acute
phase proteins, e.g. alpha-1-acid glycoprotein (AGP), serum amy-
loid A (SAA) and ovotrensferrin (OVT) was performed by immu-
noassays to validate the LC-MS results. The data contained within
this article are directly related to our research article”Quantitative
proteomics using tandem mass tags in relation to the acute phase
protein response in chicken challenged with Escherichia coliis an open access article under the CC BY license
jprot.2018.08.009
illemin).
S
M
T
H
D
E
E
D
D
A. Horvatić et al. / Data in Brief 21 (2018) 684–699 685lipopolysaccharide endotoxin” [1]. The raw mass spectrometric data
generated in this study were deposited to the ProteomeXchange
Consortium via the PRIDE partner repository with the dataset
identiﬁer PXD009399 (http://proteomecentral.proteomexchange.
org/cgi/GetDataset?ID¼PXD009399).
& 2018 Published by Elsevier Inc. This is an open access article
under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations tableubject area Veterinary medicine, Biomedicine
ore speciﬁc subject area Proteomics, statistics, bioinformatics, immunoassays
ype of data Excel ﬁles, graphs, ﬁgures
ow data was acquired 1. LC-MS/MS analysis was performed using Ultimate 3000 RSLCnano sys-
tem (Dionex, Germering, Germany) coupled to Q Exactive Plus mass
spectrometer (Thermo Fisher Scientiﬁc, Bremen, Germany).
2. Acute phase proteins absolute quantiﬁcation was performed using ELISA
tests (for AGP, SAA) and radial immunodiffusion (for OVT).ata format Integration of raw and analyzed data
xperimental factors Non-depleted plasma samples
xperimental features Quantitative proteomic, bioinformatic and immunoassay analyses of
chicken serum
ata source location University of Glasgow Cochno Farm & Research Centre, Glasgow,
United Kingdom
ata accessibility The mass spectrometry proteomics raw data have been deposited to the
ProteomeXchange Consortium via the PRIDE partner repository with the
dataset identiﬁer PXD009399MS (http://proteomecentral.proteo
mexchange.org/cgi/GetDataset?ID¼PXD009399). All other data are
available within this article.Value of the data
 This data provides information about changes in plasma proteome in chickens challenged with
Escherichia coli lipopolysaccharide during 72 h with the emphasis on acute phase proteins such as
alpha-1-acid glycoprotein (AGP), serum amyloid A (SAA) and ovotrensferrin (OVT).
 Peptide/protein information and pathway analysis datasets might be useful as a basis for future
targeted analysis of proteins deregulated during inﬂammation.
 The data can be useful for other researchers investigating inﬂammation or pathophysiological
mechanisms in veterinary medicine as well as in biomedical research.1. Data
Protein and peptide identiﬁcations, as well as their corresponding peptide spectrum matches
(PSMs), obtained by label-based proteomic approach, in plasma from chicken challenged with
Escherichia coli lipopolysacharride (LPS) endotoxin (2mg/kg body weight) pre (0 h) and at 12, 24, 48,
and 72 h post injection along with plasma from a control group (N¼6) challenged with sterile saline
are reported, with the corresponding peptide spectrum matches (PSMs). Furthermore, relative
A. Horvatić et al. / Data in Brief 21 (2018) 684–699686quantiﬁcation data after statistical analysis together with subsequent pathway analysis results and
immunoassays data are also presented.
Results of analyze performed on this dataset has been represented in different ﬁgures and tables
included in this Data in Brief article.
Fig. 1 represent fold changes of proteins between LPS-treated and saline groups, and their asso-
ciated p-values.
Fig. 2 represent how time affect proteins quantities in LPS animals.
Fig. 3 represent pathways up and down regulated, associated with LPS treatment.
Fig. 4 represent pathways affected by time, associated with LPS treatment. Evolution of proteins
fold changes (LPS vs saline groups) are represented for each time-affected proteins.
Fig. 5 represent quantiﬁcation of 3 proteins (α1-acid glycoprotein, SAA, ovotransferrin) performed
by ELISA at 5 time points (0, 12, 24, 48 and 72 h).
Fig. 6 represent differences in fold changes (LPS vs saline) between 4 times points (12, 24, 48, 72 h)
and 0 h, to compare ELISA and LS-MS quantiﬁcation.
Table 1 list proteins signiﬁcantly different between LPS and saline group, with their associated fold
changes and p-values.
Table 2 list proteins signiﬁcantly different between LPS and saline group which are affected by
time effect, with associated fold changes among time and p-values.
Table 3 list GO terms associated by LPS challenge, with their associated p-values.
Table 4 list GO terms associated by LPS challenge and time, with their associated p-values.
Table 5 present different group and time effects for the proteins SAA, AGP and OVT, quantiﬁed
by ELISA.
Table 6 present results about time effect on proteins AGP, SAA and OVT, between LPS stimulated
samples and controls, and inside the LPS-stimulated group.2. Experimental design, materials and methods
In March and April 2017 one day old, Ross 308 broiler chicks (PD Hook Hatcheries Ltd, Bampton, UK),
were ﬁtted with unique wing tags and housed in 4 groups of 14 in adjacent 1m  2m pens on a litter
of wood shavings on the University of Glasgow Cochno Farm & Research Centre. Broiler mash and waterFig. 1. Volcano plot for chicken challenged with Escherichia coli lipopolysaccharide endotoxin versus saline group. Volcano plot
of fold changes (x-axis) and their associated log10 transformed p-values (y-axis) for the 571 peptides analysed by LC-MS.
Peptides signiﬁcantly different between saline and LPS groups (log10 p41.3) are in black, non-signiﬁcant peptides
(log10 po1.3) are in grey.
Fig. 2. Time-affected proteins in chicken challenged with Escherichia coli lipopolysaccharide endotoxin (LPS group). Barplot of
the mean and SEM of 19 proteins differentially expressed for the different time points (0 h, 12 h, 24 h, 48 h, 72 h) in LPS group.
Proteins have been grouped according to their pattern of expression: A or B and C. Patterns have been deﬁned according to the
evolution of fold changes among time.
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room. All chickens were conﬁrmed to be climatized to handling by 15 days old. Room temperature was
maintained within the thermal neutral zone at 18 °C (range 18.0–18.3) and a 20 h:4 h light: dark cycle
was implemented.
The experiment commenced when the chickens were 15 days old. Twenty four birds were injected
subcutaneously (SC) at time point 0, with Escherichia coli lipopolysaccharide (LPS from E. coli O111:B4
puriﬁed by phenol extraction, L2630-25MG; Sigma-Aldrich, Dorset, UK) (2mg/kg body weight) in a
volume of 0.5mL as the treatment group and another 24 birds injected SC by sterile normal saline
(0.5mL) as a control group. There were 5 blood sampling time points; pre (0 h) and post injection (PI)
at 12, 24, 48, and 72 h. Plasma was collected from the same 6 chicken in the treated group and from
the same 6 chicken in the untreated group, subsequently, at each time point for further analyses by
proteomic and immunoassay methods. The remaining 18 birds in each group were not used in the
plasma proteome investigation. Approximately 1.2mL of blood was collected from the wing vein
Fig. 3. Interactome of pathways differentially expressed between chicken challenged with Escherichia coli lipopolysaccharide
endotoxin and saline, and their intermediate proteins. Gene ontology analysed pathways and proteins over-represented in LPS
compared with saline samples. This analyse have been done with the Cytoscape application ClueGO and the REVIGO tool for GO
terms selection. GO terms and proteins over-expressed in LPS are in green, lower-expressed in LPS are in red. GO terms in grey
could not be attributed speciﬁcally to over or lower expressed terms/proteins. GO terms in bold represent GO terms selected to
be the most representative of their GO group deﬁned by the REVIGO tool. The yFiles radial layout algorithm was applied.
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at 4 °C and the plasma aspirated and immediately frozen at 20 °C.
After the trial, all chickens were culled by over dose (1.5–2mL/bird) i.v. injection of barbiturate
(Euthatal 200mg/mL, Merial, Woking, UK). Research was conducted under Home Ofﬁce license
(60/4466), and approved by ethical review of the University of Glasgow, MVLS College Ethics
Committee.3. Proteomic investigation of chicken plasma
Proteomic analysis of chicken plasma samples was performed by applying TMT-based quantitative
gel-free approach as described previously [2]. In brief, after total protein concentration determination
using BCA assay (Thermo Scientiﬁc, Rockford, USA), 35 mg of total plasma proteins from samples and
internal standard (pool of all samples) were diluted to a volume of 50 mL using 0.1M triethyl
ammonium bicarbonate (TEAB, Thermo Scientiﬁc, Rockford, USA), reduced by adding 2.5 mL of
Fig. 4. Interactome of pathways differentially expressed among time in chicken challenged with Escherichia coli lipopoly-
saccharide (LPS group) and their intermediate proteins. Gene ontology analysed pathways over-represented in the list of 19
proteins differentially expressed among time in LPS group. This analyse have been done with the Cytoscape application ClueGO
and the REVIGO tool for GO terms selection. GO terms in bold represent GO terms selected to be the most representative of
their GO group deﬁned by the REVIGO tool. For each proteins, 4 fold changes among the 5 different time points have been
represented using colour intensity to ﬁgure fold change value. Positive fold changes are in green, negative are in red, fold
change values close to 0 are in white. Proteins have been gather in 3 groups deﬁned by their fold changes pattern. The A pattern
correspond to a quick increase of a protein, then go back to the initial situation, while the pattern B correspond to a quick
decrease of a protein and then a go back to the initial situation. The C pattern correspond to a decrease which happen later in
the infection process. For each pattern, evolution of one protein mean among time has been represented with histogram to
illustrate the pattern properties.
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IAA (30min, room temperature in the dark) (Sigma Aldrich, St. Lois, MO, USA) and acetone-
precipitated (addition of 300 mL, overnight, 20 °C). Protein pellets were collected subsequently by
centrifugation (8000g, 4 °C), dissolved in 50 mL of 0.1M TEAB and digested using 1 mL of trypsin
(1mg/mL, Promega; trypsin-to-protein ratio 1:35, at 37 °C overnight). TMT sixplex reagents (Thermo
Scientiﬁc, Rockford, IL, USA) were prepared according manufacturer's procedure and an amount of
19 mL of the appropriate TMT label was added to each sample used for the labelling reaction (60min,
room temperature) which was quenched using 5% hydroxylamine (Sigma-Aldrich, St. Louis, MO, USA).
Five TMT-modiﬁed peptide samples were combined with the internal standard (labelled with
TMT m/z 126) into the new tube, aliquoted, dried and stored at 20 °C for further analysis. A total of
30 samples (6 chicken at 5 time points) from treated and 30 samples from control chicken led to 12
individual TMT experiments with the inclusion of internal standards in each experiment.
High resolution LC-MS/MS analysis of TMT-labelled peptides was carried out using an Ultimate 3000
RSLCnano system (Dionex, Germering, Germany) coupled to a Q Exactive Plus mass spectrometer
(Thermo Fisher Scientiﬁc, Bremen, Germany). Peptides were loaded onto the trap column
(C18 PepMap100, 5 mm, 100 A, 300 mm  5mm), desalted for 12min at the ﬂow rate of 15 uL/min and
separated on the analytical column (PepMap™ RSLC C18, 50 cm  75 μm) using linear gradient
5–45% mobile phase B (0.1% formic acid in 80% ACN) over 120min, 45% to 90% for 2min, held at 80% for
2min and re-equilibrated at 5% B for 20min at the ﬂow rate of 300 nL/min. Loading solvent consisted of
0.1% formic acid and 2% ACN in water, while mobile phase A contained 0.1% formic acid in water.
Ionisation was achieved using nanospray Flex ion source (Thermo Fisher Scientiﬁc, Bremen, Germany)
Fig. 5. ELISA quantiﬁcation of alpha-1-acid glycoprotein (AGP), serum amyloid A (SAA), and ovotransferrin (OVT) in different
time points. Quantity of each proteins have been represented among time points, for the 2 groups: LPS (continuous line) and
saline (dash line). To better visualize difference in SAA, quantities have been transformed by the function log10 for the ﬁgure.
SEM for each groups and time points have been added. Signiﬁcance of differences between LPS and saline group for each time
point separately have been represented. *po0.05, **po0.01 and t: p40.05.
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ion mode using DDA Top8 method. The lock mass feature was not in use in this experiment. Full scan
MS spectra were acquired in range from m/z 350.0 to m/z 1800.0 with a resolution of 70,000, 120ms
injection time, AGC target 1E6, a72.0 Da isolation window and the dynamic exclusion 30 s. HCD
fragmentation was performed at step collision energy (29% and 35% NCE) with a resolution of 17,500
and AGC target of 2E5. Precursor ions with unassigned charge state, as well as charge states of þ1 and
more than þ7 were excluded from fragmentation. MS2 was operated in centroid mode.
For peptide identiﬁcation and relative quantiﬁcation the SEQUEST algorithm implemented into Pro-
teome Discoverer (version 2.0., Thermo Fisher Scientiﬁc) was used. Database search against Gallus gallus
Fig. 6. Comparison of 4 fold changes among 5 time points performed by ELISA and LC-MS on alpha-1-acid glycoprotein (AGP),
serum amyloid A (SAA), and ovotransferrin (OVT). Fold changes values have been represented for the 3 proteins to establish a
comparison between ELISA and LC-MS quantiﬁcations: AGP/ORM1 (A), OVT/TF (B), and SAA/HPS5 (C).
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Release ID 103) was performed according to the following parameters: two trypsin missed cleavage sites,
precursor and fragment mass tolerances of 10 ppm and 0.02Da, respectively; carbamidomethyl (C) ﬁxed
peptide modiﬁcation, oxidation (M), deamidation (N,Q) and TMT sixplex (K, peptide N-terminus) dynamic
modiﬁcations. The false discovery rate (FDR) for peptide identiﬁcationwas calculated using the Percolator
algorithm in the Proteome Discoverer workﬂow based on the search results against a decoy database and
was set at 1% FDR. Only proteins with at least two unique peptides and less than 5% FDR were reported as
reliable identiﬁcation. Protein quantiﬁcation was accomplished by correlating the relative intensities of
reporter ions extracted from tandem mass spectra to that of the peptides selected for MS/MS fragmen-
tation The internal standard was used to compare relative quantiﬁcation results for each protein between
the experiments (sixplexes). Peptide and protein identiﬁcation data are shown in Supplementary ﬁle 1.
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium
via the PRIDE partner repository [3] with the dataset identiﬁer PXD009399.
Table 1
Proteins with signiﬁcantly differential abundances between LPS and saline groups identiﬁed using TMT approach.
Gene Symbol
(Gallus gallus) Protein name P-value
(FDR)
Fold
Change
HPS5 serum amyloid A protein 2.20E-03 1.24
SERPINA3 alpha-1-antiproteinase* 7.89E-07 1.02
HPX haemopexin* 5.35E-06 0.79
ORM1 alpha 1-acid glycoprotein 1.05E-05 0.66
LCN8 extracellular fatty acid-binding protein
precursor
7.62E-03 0.65
TF ovotransferrin 3.61E-06 0.49
CP ceruloplasmin* 1.14E-03 0.48
SMC4 condensin complex subunit 1.94E-03 0.47
LOC107051143 complement C3-like* 2.09E-05 0.43
CFD complement factor D, partial* 1.05E-04 0.34
LOC423629 uncharacterized protein LOC423629* 1.87E-03 0.33
LOC419851 complement regulatory soluble
protein
9.47E-03 0.32
PIT54 PIT 54 1.17E-04 0.29
LOC100858647 beta-microseminoprotein-like* 2.99E-03 0.28
FGA Fibrinogen alpha chain precursor 4.45E-05 0.26
CLU clusterin isoform X1* 6.86E-03 0.21
FGB Fibrinogen beta chain precursor 2.46E-04 0.21
FGG ﬁbrinogen gamma chain precursor 1.10E-04 0.21
C3 complement C3 precursor 1.41E-03 0.19
IGLL1 immunoglobulin light chain variable
region, partial
1.79E-02 0.18
CFHR2 complement factor H* 1.64E-05 0.17
SPINK5 ovoinhibitor 2.87E-02 0.17
A2ML4 alpha-2-macroglobulin-like protein 1* 8.86E-03 0.17
VNN1 pantetheinase precursor 3.69E-02 0.17
APOH beta-2-glycoprotein 1 precursor 3.50E-03 0.15
FETUB fetuin-B precursor 8.55E-06 0.15
PLG plasminogen* 3.20E-06 0.12
ATRN attractin isoform X3* 3.08E-02 0.11
LOC418892 uncharacterized protein 2.78E-02 0.11
CST3 cystatin precursor 2.25E-02 0.10
TNC tenascin 4.09E-02 0.11
ITIH3 inter-alpha-trypsin inhibitor heavy
chain H3 isoform X1*
4.21E-02 0.12
AGRN basement membrane-speciﬁc heparan
sulfate proteoglycan core protein
precursor
2.51E-02 0.12
ITIH2 inter-alpha-trypsin inhibitor heavy
chain H2 precursor
1.96E-02 0.12
IGFALS insulin-like growth factor-binding
protein complex acid labile subunit
isoform X1*
3.71E-03 0.13
HSPG2 basement membrane-speciﬁc heparan
sulfate proteoglycan core protein*
1.79E-02 0.13
HRG histidine-rich glycoprotein* 1.51E-02 0.14
COL5A1 alpha 1 (V) collagen 2.79E-02 0.14
KNG1 kininogen-1* 1.19E-03 0.14
C1QTNF3 complement C1q tumor necrosis fac-
tor-related protein 3 isoform X1*
8.85E-03 0.14
F13A1 coagulation factor XIII A chain 4.15E-02 0.14
LUM lumican precursor 2.45E-03 0.14
AHSG alpha-2-HS-glycoprotein* 3.98E-02 0.14
GIF hypothetical protein RCJMB04_7i4 3.80E-02 0.15
PROS1 vitamin K-dependent protein S* 1.42E-02 0.15
APOA2 apolipoprotein A-II* 2.47E-02 0.16
A. Horvatić et al. / Data in Brief 21 (2018) 684–699692
Table 1 (continued )
Gene Symbol
(Gallus gallus) Protein name P-value
(FDR)
Fold
Change
ANPEP aminopeptidase, partial 2.11E-02 0.16
LOC107056848 cadherin-5-like, partial* 7.56E-03 -0.17
VTN vitronectin precursor 1.59E-05 0.17
CL2 ribonuclease CL2 precursor 1.69E-02 0.17
LOC107055759 vitamin K-dependent protein S-like* 7.86E-03 0.17
APOA1 apolipoprotein A-I 1.64E-05 0.18
FBLN1 ﬁbulin-1, isoform D precursor 3.85E-02 0.18
APOA4 apolipoprotein A-IV precursor 4.10E-04 0.19
IL6ST interleukin-6 receptor subunit beta
precursor
4.32E-05 0.20
TFRC chicken transferrin receptor 2.19E-04 0.20
SPARC basement-membrane protein 40
precursor
3.29E-02 0.20
F13B coagulation factor XIII B chain isoform
X1*
9.61E-03 0.20
LOC100857892 sushi, nidogen and EGF-like domain-
containing protein 1 isoform X1*
8.56E-03 0.20
LOC107050076 IgGFc-binding protein-like, partial* 4.78E-03 0.21
SERPINF1 pigment epithelium-derived factor
precursor
3.03E-06 0.21
CLEC3B tetranectin precursor 7.32E-03 0.22
SERPINC1 antithrombin-III* 1.39E-06 0.23
SERPINA4 serpin peptidase inhibitor, clade A
(alpha-1 antiproteinase, antitrypsin),
member 4 precursor
3.23E-04 0.23
LOC771012 coagulation factor X-like* 4.19E-03 0.23
ENO1 alpha-enolase 6.46E-03 0.23
LOC100858068 IgGFc-binding protein-like, partial* 2.32E-02 0.23
RBP4A E Chain E, Retinol Binding Protein
Complexed With Transthyretin
2.26E-04 -0.25
FN1 ﬁbronectin, partial 9.44E-03 0.26
SERPINA5 alpha-1-antitrypsin isoform X1* 2.49E-04 0.28
TGFBI transforming growth factor-beta-
induced protein ig-h3 precursor
3.84E-06 0.28
HBG2 beta-globin 1.46E-02 0.29
LCAT lecithin-cholesterol acyltransferase,
partial
1.14E-02 0.29
C4 complement C4 precursor 3.37E-02 0.30
ALPP intestinal-type alkaline phosphatase* 1.27E-02 0.30
POSTN periostin precursor 3.16E-06 0.32
COL1A1 collagen alpha-1(I) chain* 2.52E-05 0.36
SCARA5 scavenger receptor class A member
5 isoform X1*
1.97E-02 0.36
LOC776376 pentraxin-related precursor 1.82E-02 0.39
HBAD alpha-D globin 3.10E-02 0.43
COL6A1 collagen alpha-1(VI) chain precursor 2.07E-06 0.44
CPN2 carboxypeptidase N subunit 2* 2.11E-05 0.46
LRRC15 uncharacterized protein LRRC15* 2.11E-05 0.46
HBAA hemoglobin subunit alpha-A chain 7.37E-03 0.48
KRT8 keratin, type II cytoskeletal 8* 3.35E-02 0.50
LOC107055417 keratin, type II cytoskeletal 8-like,
partial*
3.35E-02 0.50
COL1A2 collagen alpha-2(I) chain precursor 7.52E-04 0.51
All proteins belong to the Gallus gallus proteome (UniprotKB).
* Proteins predicted in Gallus gallus, with no evidence of existence to date at protein, transcript or homology levels.
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Table 2
Proteins with signiﬁcantly differential abundances during time in chicken challenged with Escherichia coli lipopolysaccharide
endotoxin.
Gene symbol P value
(FDR)
Fold change
(12 h/0 h)
Fold change
(24 h/0 h)
Fold change
(48 h/0 h)
Fold change
(72 h/0 h)
A2ML4 1.57E-02 0.34 0.44 0.31 0.19
AHSG 1.06E-02 0.43 0.15 0.04 0.13
APOA2 1.37E-02 0.36 0.49 0.19 0.30
C3 4.39E-02 0.18 0.35 0.35 0.19
CFD 1.89E-02 0.42 0.61 0.62 0.43
COL1A1 3.39E-02 0.62 0.42 0.42 0.23
CP 3.16E-03 1.02 1.05 0.51 0.21
FGA 9.93E-03 0.29 0.38 0.23 0.03
FGB 1.03E-02 0.26 0.34 0.24 0.03
FGG 9.19E-03 0.23 0.33 0.23 0.01
HPS5 5.44E-03 2.27 1.35 0.35 -0.29
HPX 7.81E-03 0.76 1.20 1.21 0.94
ITIH2 4.46E-02 0.19 0.05 0.02 0.04
LCN8 1.82E-02 1.78 1.02 0.66 0.21
ORM1 5.01E-03 0.93 1.18 0.76 0.42
POSTN 2.18E-02 0.06 0.30 0.35 0.15
SERPINA3 4.31E-03 1.24 1.35 0.99 0.73
TF 1.54E-02 0.51 0.55 0.41 0.30
TGFBI 1.50E-02 0.34 0.52 0.29 0.24
A. Horvatić et al. / Data in Brief 21 (2018) 684–6996944. Statistical and bioinformatics analysis of the chicken plasma proteome
4.1. Statistics for proteomics
All statistics were performed using R (v3.4.3) [4] under RStudio environment (v1.0.143) [5].
Infection effect (saline versus LPS) and time effect in infection groups (0 h,12 h,24 h,48 h,72 h in saline
and LPS separately) were considered for investigation. A peptide was not considered for the analysis if
one of its group (infection, time or infection x time) had more of 50% of missing data after LC-MS
identiﬁcation and quantiﬁcation. Filtered data are shown in Supplementary ﬁle 2.
A two-way ANOVAwas performed to model the effect of treatment and time on the quantity of the
peptides, using a linear regression model. Distribution of residuals generated by the ANOVA was
accessed by a Shapiro-Wilk test. A Kruskal-Wallis test was performed to access the effect of treatment
and time on peptides quantity using the R package “PMCMRplus” [6]. Due to multiple comparisons
performed, a local False Discovery Rate was applied using the R package “qvalue” [7]. Each p-value
was transformed by the function -log10(x). Obtained data are presented in Figs. 1 and 2, as well as in
Tables 1 and 2 of Ref [1].
Fold change between the 2 groups has been calculated by the function log2(Mean(Group2)/Mean
(Group1)). A volcano plot was designed using the R package “plotly” [8]. Plots were generated with
the “ggplot2” package [9]. Spearman's correlation were calculated to estimate the relationship
between ELISA and LC-MS quantiﬁcations for the proteins AGP, SAA and OVT (Fig. 6 of Ref [1]).
All operations were scripted in R to assure the automatization of the statistics pipeline to all
peptides.
4.2. Bioinformatics
Proteins ID (Gallus gallus) were converted into Gene ID (Gallus gallus) by the platform DAVID
(david-d.ncifcrf.gov/conversion.jsp) conversion tool. Gene Ontology enrichment analysis was per-
formed using the Cytoscape (v3.6.0) [10] plugin ClueGO (v2.5.0) [11] on GO-Biological Processes
(08/03/2018).
Table 3
GO terms over-represented in chicken challenged with Escherichia coli lipopolysaccharide endotoxin vs saline group.
GOID GOTerm Term
p-value
Genes Cluster Redundant Leader Group
GO:0072378 blood coagulation, ﬁbrin clot formation 1.18E-12 6 No speciﬁc GO:0052547
GO:0031589 cell-substrate adhesion 1.76E-04 7 No speciﬁc Yes GO:0031589
GO:0015893 drug transport 6.75E-03 4 Negative GO:1902042
GO:0035987 endodermal cell differentiation 5.95E-04 3 Negative GO:0052547
GO:0030198 extracellular matrix organization 6.46E-03 4 Negative GO:0043062
GO:0043062 extracellular structure organization 8.25E-04 6 Negative Yes GO:0043062
GO:0030195 negative regulation of blood coagulation 1.75E-06 5 Positive Yes NA
GO:0010951 negative regulation of endopeptidase activity 9.55E-18 16 Negative Yes NA
GO:2000352 negative regulation of endothelial cell apoptotic process 4.89E-04 3 Positive GO:1902042
GO:1902042 negative regulation of extrinsic apoptotic signaling pathway via death
domain receptors
4.17E-04 3 Positive Yes GO:1902042
GO:0031639 plasminogen activation 3.14E-04 3 Positive GO:0052547
GO:0070527 platelet aggregation 4.19E-03 3 Positive Yes NA
GO:0022409 positive regulation of cell-cell adhesion 3.36E-03 4 Positive GO:0031589
GO:0045921 positive regulation of exocytosis 4.19E-03 3 Positive Yes NA
GO:0090277 positive regulation of peptide hormone secretion 4.94E-04 4 Positive GO:1902042
GO:0050714 positive regulation of protein secretion 4.76E-03 4 Positive Yes NA
GO:0045907 positive regulation of vasoconstriction 6.99E-04 3 Positive GO:0052547
GO:0072376 protein activation cascade 2.79E-13 9 No speciﬁc GO:0052547
GO:0016485 protein processing 1.58E-03 5 Positive Yes NA
GO:0030193 regulation of blood coagulation 6.70E-08 7 No speciﬁc Yes NA
GO:0010810 regulation of cell-substrate adhesion 9.15E-03 3 Negative Yes NA
GO:0051336 regulation of hydrolase activity 1.52E-10 20 Negative GO:0052547
GO:0052547 regulation of peptidase activity 1.62E-17 18 Negative Yes GO:0052547
GO:0051592 response to calcium ion 4.15E-03 3 Positive GO:1902042
GO:0042060 wound healing 7.79E-07 10 Negative Yes NA
GO terms were determined by Cytoscape/ClueGO and then analysed by REVIGO. GO terms in bold have been identiﬁed as the most representative of their GO group by the tool REVIGO.
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Table 4
GO terms over-represented in chicken challenged with Escherichia coli lipopolysaccharide endotoxin during time.
GOID GOTerm Term p-value Genes Redundant Leader Group
GO:0006953 acute-phase response 7.12E-06 3 GO:0072376
GO:0010951 negative regulation of endopeptidase activity 3.40E-05 4 GO:0072376
GO:0072376 protein activation cascade 6.11E-07 4 Yes GO:0072376
GO:0034116 positive regulation of heterotypic cell-cell adhesion 4.60E-07 3 Yes GO:0034116
GO:0051592 response to calcium ion 5.96E-05 3 GO:0072376
GO:0070527 platelet aggregation 5.32E-05 3 Yes GO:0072376
GO:0045921 positive regulation of exocytosis 5.32E-05 3 Yes GO:0072376
GO:0042730 ﬁbrinolysis 3.15E-06 3 GO:0072376
GO:0045907 positive regulation of vasoconstriction 7.12E-06 3 GO:0072376
GO:0050714 positive regulation of protein secretion 1.72E-04 3 Yes GO:0072376
GO:0090277 positive regulation of peptide hormone secretion 4.96E-05 3 GO:0072376
GO:0031639 plasminogen activation 3.15E-06 3 GO:0072376
GO:1902042 negative regulation of extrinsic apoptotic signaling pathway via death domain receptors 3.99E-06 3 GO:0072376
GO:2000352 negative regulation of endothelial cell apoptotic process 4.80E-06 3 GO:0072376
GO terms were determined by Cytoscape/ClueGO and then analysed by REVIGO. GO terms in bold have been identiﬁed as the most representative of their GO group by the tool REVIGO.
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Table 5
P-values of group and time effects on alpha-1-acid glycoprotein (AGP), serum amyloid A (SAA), and ovotransferrin (OVT)
proteins quantiﬁed by ELISA.
Protein Group Group x time Time - LPS group Time – saline group
AGP o0.001 o0.001 o0.001 NS
SAA o0.001 o0.001 o0.001 NS
OVT o0.001 o0.001 o0.001 NS
NS: Not Signiﬁcant (p40.05). Group effect was assessed between LPS and saline samples by Wilcoxon-test (2-sided). Mixed
Group x Time and Time effects were assessed by a Kruskal-Wallis test.
Table 6
Time effect for alpha-1-acid glycoprotein (AGP), serum amyloid A (SAA), and ovotransferrin (OVT) proteins quantiﬁed by ELISA.
A. Effect of group (LPS versus saline) for each time point, saline used as reference to compare. B. Effect of time on proteins fold
change compared with 0 h (reference level).
A. Group effect (LPS versus saline) for each time point
0 h 12 h 24 h 48 h 72 h
AGP Fold change 0.04 1.29 1.68 1.18 0.96
P value NS o0.01 o0.01 o0.05 NS
SAA Fold change 0.73 5.21 1.90 1.71 0.01
P value NS o0.01 o0.01 o0.05 NS
OVT Fold change 0.06 0.78 1.05 0.90 0.62
P value NS o0.01 o0.01 o0.01 o0.1
B. Time effect in LPS group compared with 0 h
12 h/0 h 24 h/0 h 48 h/0 h 72 h/0 h
AGP Fold change 2.16 2.11 1.22 0.91
P value o0.01 o0.01 o0.05 NS
SAA Fold change 5.77 2.58 0.44 1.53
P value o0.01 o0.01 NS NS
OVT Fold change 1.06 1.41 1.13 0.92
P value o0.01 o0.01 o0.01 o0.01
NS: Not Signiﬁcant (p40.05). Differences were assessed with a Wilcoxon-test (2-sided).
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the 2 groups were set: one cluster for over-expressed proteins following LPS treatment, the other for
proteins exhibiting lower-expression following LPS. The analysis was performed using the following
parameters: evidence code¼All, GO levels 3 to 15, minimal number of gene¼3, minimal percentage
of gene¼3, Kappa score threshold¼0.4, p-values corrected by Bonferroni step down.
For time effect, differentially expressed proteins with time were analyzed at once using the fol-
lowing parameters: evidence code¼All, GO levels 3 to 8, minimal number of gene¼3, minimal
percentage of gene¼3, Kappa score threshold¼0.4, p-values corrected by Bonferroni step down.
The two lists of GO terms over-expressed in the context of group and time effects were submitted
to an analysis by REVIGO (revigo.irb.hr) [12] to remove redundant GO terms and group similar terms
based on their description. For both analyses, the database used was Gallus gallus, with the SimReal
semantic similarity measure.
Pathways of relationship between GO terms ﬁltered according to REVIGO with their proteins/
genes were designed on Cytoscape. Fold change data was included for the time effect analysis on
samples from the LPS treated group. Pathway analysis data are shown in Figs. 3 and 4, as well as in
Tables 3 and 4 of Ref [1].
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5.1. Immunoassays
The concentrations of AGP, SAA and OVT were determined in the plasma according to previously
described procedures [13]. The ELISA assays for chicken AGP and SAA were obtained from Life
Diagnostics Inc (West Chester, USA). They were performed according to the manufacturer's instruc-
tions with a dilution factor for the plasma samples of 1:10,000 for AGP and 1:20 for SAA. Each
individual sample was run in duplicate. The plasma concentration of OVT was assessed by radial
immunodiffusion (RID) using speciﬁc antibody for chickens OVT as described previously [50]. Data are
presented in Fig. 5 of Ref [1].
5.2. Statistics for immunoassays
Statistics on immunoassay were performed by non-parametric tests due to group size and dis-
tribution. Group effect was assessed by a Wilcoxon-test (2-sided), and a Kruskal-Wallis test was used
to assess mixed effect Group x Time on all groups and Time effect on LPS and saline groups separately.
For each time point (0 h/12 h/24 h/48 h/72 h), difference between LPS and saline was assessed by a
Wilcoxon-test (2-sided) and fold change of expression calculated between times 12 h/24 h/48 h/72 h
versus 0 h in LPS group. Correlation between these proteins was assessed on LPS group by a Spearman
rank test. Immunoassays-related statistical data are shown in Tables 5 and 6 of Ref. [1].Acknowledgements
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